Gavreto, RET Inhibitor, FDA Approved for Metastatic NSCLC with RET Fusions

Garraway, L

AMERICAN HEALTH AND DRUG BENEFITS, 2020; 13 (5): 213

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索